Impact of Itch on Sleep Disturbance in Patients with Prurigo Nodularis
DOI:
https://doi.org/10.2340/00015555-3778Keywords:
itch, pruritus, prurigo nodularis, PN, atopic dermatitis, AD, sleepAbstract
Abstract is missing (Short communication)
Downloads
References
Silverberg JI, Kantor RW, Dalal P, Hickey C, Shaunfield S, Kaiser K, et al. A comprehensive conceptual model of the experience of chronic itch in adults. Am J Clin Dermatol 2018; 19: 759-769.
DOI: https://doi.org/10.1007/s40257-018-0381-6
Steinke S, Zeidler C, Riepe C, Bruland P, Soto-Rey I, Storck M, et al. Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial. J Am Acad Dermatol 2018; 79: 457-463.
DOI: https://doi.org/10.1016/j.jaad.2018.04.044
Lavery MJ, Stull C, Nattkemper LA, Sanders KM, Lee H, Sahu S, et al. Nocturnal pruritus: prevalence, characteristics, and impact on ItchyQoL in a chronic itch population. Acta Derm Venereol 2017; 97: 513-515.
DOI: https://doi.org/10.2340/00015555-2560
Todberg T, Zachariae C, Skov L. Treatment and burden of disease in a cohort of patients with prurigo nodularis: a survey-based study. Acta Derm Venereol 2020; 100: adv00119.
DOI: https://doi.org/10.2340/00015555-3471
Konda D, Chandrashekar L, Rajappa M. Kattimani S, Thappa DM, Ananthanarayanan PH. Serotonin and interleukin-6: association with pruritus severity, sleep quality and depression severity in prurigo nodularis. Asian J Psychiatr 2015; 17: 24-28.
DOI: https://doi.org/10.1016/j.ajp.2015.07.010
Spring P, Gschwind I, Gilliet M. Prurigo nodularis: retrospective study of 13 cases managed with methotrexate. Clin Exp Dermatol 2014; 39: 468-473.
DOI: https://doi.org/10.1111/ced.12365
Sharma AD. Oral ketotifen and topical antibiotic therapy in the management of pruritus in prurigo nodularis: a randomized, controlled, single-blind, parallel study. Indian J Dermatol 2013; 58: 355-359.
DOI: https://doi.org/10.4103/0019-5154.117300
Oh CC, Li H, Lee W, Tey HL. Biopsychosocial factors associated with prurigo nodularis in endogenous eczema. Indian J Dermatol 2015; 60: 525.
DOI: https://doi.org/10.4103/0019-5154.164451
Dawn A, Papoiu AD, Chan YH, Rapp SR, Rassette N, Yosipovitch G. Itch characteristics in atopic dermatitis: results of a web-based questionnaire. Br J Dermatol 2009; 160: 642-644.
DOI: https://doi.org/10.1111/j.1365-2133.2008.08941.x
Desai NS, Poindexter GB, Monthrope YM, Bendeck SE, Swerlick RA, Chen SC. A pilot quality-of-life instrument for pruritus. J Am Acad Dermatol 2008; 59: 234-244.
DOI: https://doi.org/10.1016/j.jaad.2008.04.006
Gwillim EC, Janmohamed SR, Yousaf M, Patel KR, Silverberg JI. The impact of prurigo nodularis on sleep disturbance and related impact: a systematic review. J Eur Acad Dermatol Venereol 2020; 34: e815-e817.
DOI: https://doi.org/10.1111/jdv.16696
Pereira MP, Hoffmann V, Weisshaar E, Wallengren J, Halvorsen JA, Garcovich S, et al. Chronic nodular prurigo: clinical profile and burden. A European cross-sectional study. J Eur Acad Dermatol Venereol 2020; 34: 2373-2383.
DOI: https://doi.org/10.1111/jdv.16309
Ferrucci S, Tavecchio S, Berti E, Angileri L. Dupilumab and prurigo nodularis-like phenotype in atopic dermatitis: our experience of efficacy. J Dermatolog Treat 2019 Sep 2 [Epub ahead of print].
DOI: https://doi.org/10.1080/09546634.2019.1659479
Chiricozzi A, Maurelli M, Gori N, Argenziano G, De Simone C, Calabrese G, et al. Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo. J Am Acad Dermatol 2020; 83: 39-45.
DOI: https://doi.org/10.1016/j.jaad.2020.03.049
Ständer S, Yosipovitch G, Legat FJ, Lacour JP, Paul C, Narbutt J, et al. Trial of nemolizumab in moderate-to-severe prurigo nodularis. N Engl J Med 2020; 382: 706-716.
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Eran C. Gwillim, Leigh A. Nattkemper, Gil Yosipovitch
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
